"The goal of the relationship between Select-Tel and the Burnet Institute is to fund the development and commercialisation of highly promising research & development ("R&D") projects, initially in the fields of hepatitis diagnostics and vaccines, and antivirals against rhinoviruses (common cold) and enteroviruses. Included is a business development program for a market -ready hepatitis E diagnostic product aimed at large markets in Asia. As part of the relationship, Select-Tel will gain a right of first review and commercialisation over a selected range of other research being conducted at the Burnet Institute.
The key terms of the MOU between the company and the Burnet Institute include the following:
- Select-Tel will establish two subsidiary project companies to fund and manage existing Burnet Institute R&D projects in the fields of hepatitis diagnostics and vaccines, and antivirals for rhinovirusesand enteroviruses;
Yes the company has extensive research into rhinovirus and SARS is thought to be a very similar virus.
I have some SLT which is why I have picked up this connection......I don't think anyone else has noticed this yet
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Held